Posters

      Validation of a High Throughput Gap-Junctional Intercellular Communication (GJIC) Assay Using Cigarette Smoke Condensates

      H-Lammerich, H-P. Lammerich.; Weisensee, D.
      Conference date
      Mar 25, 2007
      Conference name
      Society of Toxicology (SOT) 2007
      Link to more information
      Link to more information
      Topic
      Summary

      Cigarette smoke condensate (CSC) is known to inhibit cell communication in a dose-dependent manner. We developed and evaluated a new high throughput GJIC assay for reproducible dose response, accuracy, and precision. An automated fluorescent microscope (ArraySCAN®, cellomics), the rat liver epithelial cell line WB-F344, and CSC from the 2R4F Kentucky reference cigarette and two single-tobacco cigarettes (i.e., bright and burley) were utilized in the evaluation. Experimental: cells were stained with the fluorescent dye calcein. Stained cells were pipetted to unstained cells of the same type and incubated for 3 h with the test substance or solvent control (0.5% DMSO). After establishing the connexin channels, the transfer of the fluorescent dye to neighboring cells within 3 h was determined and expressed as “% stained cells” as a measure of gap-junctional intercellular communication. Phorbol-12-myristate-13-acetate (TPA), a well-known inhibitor of GJIC, was used as a control. Results: the assay showed a reproducible dose response. The repeatability and reproducibility for the 2R4F were 3.7% and 6.9%, respectively; the minimal detectable difference was 5.7 µg/ml. The EC50 value for TPA was 0.34 ng/ml, which is in the range reported in the literature for other GJIC assay designs. The ec50 values for CSC from the three cigarette types were 45 µg/ml for bright, 51 µg/ml for the 2R4F, which is a mixture of bright and burley tobacco, and 58 µg/ml for burley, which had a shallower slope than the other two cigarette types. Conclusion: this cell-based assay can determine the GJIC-inhibitory activity of CSC, and meets ISO criteria for precision and accuracy. The assay can also discriminate between different CSCS, as reflected by the ec50 values for the three cigarette types. In conclusion, this screening assay is an adequate tool to determine GJIC, which has been proposed to play a role in tumor promotion.

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.